These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10691696)

  • 1. A new class of conformationally rigid analogues of 4-amino-5-halopentanoic acids, potent inactivators of gamma-aminobutyric acid aminotransferase.
    Qiu J; Silverman RB
    J Med Chem; 2000 Feb; 43(4):706-20. PubMed ID: 10691696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation and inhibition of gamma-aminobutyric acid aminotransferase by conformationally restricted vigabatrin analogues.
    Choi S; Silverman RB
    J Med Chem; 2002 Sep; 45(20):4531-9. PubMed ID: 12238932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of inactivation of gamma-aminobutyric acid-alpha-ketoglutaric acid aminotransferase by 4-amino-5-halopentanoic acids.
    Silverman RB; Levy MA
    Biochemistry; 1981 Mar; 20(5):1197-203. PubMed ID: 7225323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of potential anticonvulsant agents: mechanistic classification of GABA aminotransferase inactivators.
    Nanavati SM; Silverman RB
    J Med Chem; 1989 Nov; 32(11):2413-21. PubMed ID: 2681782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of a conformationally restricted analogue of the antiepilepsy drug Vigabatrin that directs its mechanism of inactivation of gamma-aminobutyric acid aminotransferase.
    Choi S; Storici P; Schirmer T; Silverman RB
    J Am Chem Soc; 2002 Feb; 124(8):1620-4. PubMed ID: 11853435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Amino-2-(substituted methyl)-2-butenoic acids: substrates and potent inhibitors of gamma-aminobutyric acid aminotransferase.
    Silverman RB; Durkee SC; Invergo BJ
    J Med Chem; 1986 May; 29(5):764-70. PubMed ID: 3701787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of gamma-aminobutyric acid aminotransferase by (Z)-4-amino-2-fluorobut-2-enoic acid.
    Silverman RB; George C
    Biochemistry; 1988 May; 27(9):3285-9. PubMed ID: 3390432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of cyclopropane isosteres of the antiepilepsy drug vigabatrin and evaluation of their inhibition of GABA aminotransferase.
    Wang Z; Silverman RB
    J Enzyme Inhib Med Chem; 2004 Aug; 19(4):293-301. PubMed ID: 15558944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition and substrate activity of conformationally rigid vigabatrin analogues with gamma-aminobutyric acid aminotransferase.
    Qiu J; Pingsterhaus JM; Silverman RB
    J Med Chem; 1999 Nov; 42(22):4725-8. PubMed ID: 10579835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorinated conformationally restricted gamma-aminobutyric acid aminotransferase inhibitors.
    Lu H; Silverman RB
    J Med Chem; 2006 Dec; 49(25):7404-12. PubMed ID: 17149870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism-based inactivation of gamma-aminobutyric acid aminotransferase by 3-amino-4-fluorobutanoic acid.
    Silverman RB; Roscher CL
    Bioorg Med Chem; 1996 Sep; 4(9):1521-35. PubMed ID: 8894109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-(Oxoalkyl)-substituted GABA analogues as inactivators and substrates of GABA aminotransferase.
    Burke JR; Silverman RB
    J Enzyme Inhib; 1991; 5(3):199-205. PubMed ID: 1669447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological activity of a difluoro-substituted, conformationally rigid vigabatrin analogue as a potent gamma-aminobutyric acid aminotransferase inhibitor.
    Pan Y; Qiu J; Silverman RB
    J Med Chem; 2003 Dec; 46(25):5292-3. PubMed ID: 14640537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntheses and evaluation of fluorinated conformationally restricted analogues of GABA as potential inhibitors of GABA aminotransferase.
    Wang Z; Silverman RB
    Bioorg Med Chem; 2006 Apr; 14(7):2242-52. PubMed ID: 16314106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-lactams: a new class of conformationally-rigid inhibitors of gamma-aminobutyric acid aminotransferase.
    Hopkins MH; Silverman RB
    J Enzyme Inhib; 1992; 6(2):125-9. PubMed ID: 1284428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic crystallography. Mechanism of inactivation of gamma-aminobutyric acid aminotransferase by (1R,3S,4S)-3-amino-4-fluorocyclopentane-1-carboxylic acid as elucidated by crystallography.
    Storici P; Qiu J; Schirmer T; Silverman RB
    Biochemistry; 2004 Nov; 43(44):14057-63. PubMed ID: 15518554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of gamma-aminobutyric acid aminotransferase by (S,E)-4-amino-5-fluoropent-2-enoic acid and effect on the enzyme of (E)-3-(1-aminocyclopropyl)-2-propenoic acid.
    Silverman RB; Invergo BJ; Mathew J
    J Med Chem; 1986 Oct; 29(10):1840-6. PubMed ID: 3761305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and mechanism of tetrahydrothiophene-based γ-aminobutyric acid aminotransferase inactivators.
    Le HV; Hawker DD; Wu R; Doud E; Widom J; Sanishvili R; Liu D; Kelleher NL; Silverman RB
    J Am Chem Soc; 2015 Apr; 137(13):4525-33. PubMed ID: 25781189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the steric requirements of the γ-aminobutyric acid aminotransferase active site with fluorinated analogues of vigabatrin.
    Juncosa JI; Groves AP; Xia G; Silverman RB
    Bioorg Med Chem; 2013 Feb; 21(4):903-11. PubMed ID: 23306054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of inactivation of gamma-aminobutyrate aminotransferase by 4-amino-5-fluoropentanoic acid. First example of an enamine mechanism for a gamma-amino acid with a partition ratio of 0.
    Silverman RB; Invergo BJ
    Biochemistry; 1986 Nov; 25(22):6817-20. PubMed ID: 3801394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.